Alloonc
2013
FOUNDED
OOB
STATUS
Out of Business
LATEST DEAL TYPE
Description
Operator of a biotechnology company intended to develop cellular therapeutic invention to cure cancer. The company's product, Mesenkiller uses a molecule which targets cancer cells that is linked with a radioactive particle killing both targeted and the surrounding non targeted cells, enabling cancer patients with efficient and effective therapeutic without having any systemic affects on the body.
Website
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- 1396 Milano Drive Unit 3
- West Sacramento, CA 95691
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Alloonc’s full profile, request a free trial.
Alloonc Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 01-Mar-2018 | Completed | Out of Business | |||
| 1. Accelerator/Incubator | Completed | Startup |